XML 30 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
RESERVES
12 Months Ended
Jun. 30, 2018
RESERVES [Abstract]  
RESERVES
11.
RESERVES

     
2018
  
2017
  
2016
 
  

Note
  
US$
  
US$
  
US$
 
Share-based payments reserve
  
11(b)

  
1,897,391
   
861,973
   
 
Foreign currency translation reserve
  
11(e)

  
68,917
   
318,122
   
259,320
 
       
1,966,308
   
1,180,095
   
259,320
 

(a)
Nature and purpose of reserves

(i)
Share-based payments reserve

The share-based payments reserve is used to record the fair value of Incentive Options and Performance Rights issued by the Group.

(ii)
Foreign currency translation reserve

Exchange differences arising on translation of entities whose functional currency is different to the Group’s presentation currency are taken to the foreign currency translation reserve, as described in Note 1(e).

(b)
Movements in share-based payments reserve

Date
 
Details
 
Number of
Incentive
Options
  
Number of
Performance
Rights
  
US$
 
2018
 
 
         
1 Jul 2017
 
Opening balance
  
56,450,000
   
2,200,000
   
861,973
 
Jul 17 – Jun 18
 
Grant of incentive securities1
  
28,250,000
   
400,000
   
 
31 Dec 2017
 
Expiry of performance rights
  
   
(1,100,000
)
  
 
30 May 2018
 
Exercise of incentive options
  
(5,000,000
)
  
   
(136,746
)
30 Jun 2018
 
Share based payment expense
  
   
   
1,172,164
 
30 Jun 2018
 
Closing balance
  
79,700,000
   
1,500,000
   
1,897,391
 
               
2017
              
1 Jul 2016
 
Opening balance
  
   
4,400,000
   
 
27 Sep 2016
 
Grant of Incentive Options
  
45,000,000
   
   
 
9 Dec 2016
 
Grant of Incentive Options
  
8,000,000
   
   
 
31 Dec 2016
 
Lapse of Performance Rights
  
   
(1,100,000
)
  
 
1 May 2017
 
Grant of Incentive Options1
  
3,450,000
   
   
 
30 Jun 2017
 
Lapse of Performance Rights
  
   
(1,100,000
)
  
 
30 Jun 2017
 
Share-based payment expense
  
   
   
861,973
 
30 Jun 2017
 
Closing balance
  
56,450,000
   
2,200,000
   
861,973
 
               
2016
              
1 Jul 2015
 
Opening balance
  
   
10,400,000
   
72,471
 
22 Jan 2016
 
Lapse of Performance Rights
  
   
(6,000,000
)
  
 
30 Jun 2016
 
Share-based payment expense
  
   
   
(72,471
)
30 Jun 2016
 
Closing balance
  
   
4,400,000
   
 


Notes:
1
Included in the above number of incentive securities granted during fiscal 2018 are 700,000 Incentive Options and 100,000 Performance Rights which were not issued until July 13, 2018 (2017: 3,450,0000 Incentive Options not issued until July 6, 2017).
2
For details on the valuation of Incentive Options and Performance Rights, including models and assumptions used, please refer to Note 15 of the financial statements.

(c)
Terms and conditions of Incentive Options

The Incentive Options are granted based upon the following terms and conditions:

Each Incentive Option entitles the holder to the right to subscribe for one Share upon the exercise of each Incentive Option;

The Incentive Options granted as share based payments at the end of the financial year have the following exercise prices and expiry dates:

14,000,000 Incentive Options exercisable at A$0.05 each expiring on December 31, 2019;

1,000,000 Incentive Options exercisable at A$0.08 each expiring on December 31, 2019;

16,500,000 Incentive Options exercisable at A$0.10 each expiring on December 31, 2019;

16,500,000 Incentive Options exercisable at A$0.15 each expiring on December 31, 2019;

1,300,000 Incentive Options exercisable at A$0.15 each expiring on June 30, 2020;

1,300,000 Incentive Options exercisable at A$0.20 each expiring on June 30, 2020;

3,200,000 Incentive Options exercisable at A$0.25 each expiring on June 30, 2020;

6,000,000 Incentive Options exercisable at A$0.10 each expiring on July 10, 2020;

6,000,000 Incentive Options exercisable at A$0.12 each expiring on January 10, 2021;

6,000,000 Incentive Options exercisable at A$0.16 each expiring on July 10, 2021;

6,000,000 Incentive Options exercisable at A$0.24 each expiring on July 10, 2022; and

1,900,000 Incentive Options exercisable at A$0.35 each expiring on December 31, 2020.

The Incentive Options are exercisable at any time prior to the Expiry Date, subject to vesting conditions being satisfied (if applicable);

Shares issued on exercise of the Incentive Options rank equally with the then Shares of the Company;

Application will be made by the Company to ASX for official quotation of the Shares issued upon the exercise of the Incentive Options;

If there is any reconstruction of the issued share capital of the Company, the rights of the Incentive Option holders may be varied to comply with the ASX Listing Rules which apply to the reconstruction at the time of the reconstruction; and

No application for quotation of the Incentive Options will be made by the Company.

(d)
Terms and conditions of Performance Rights

The Performance Rights are granted based upon the following terms and conditions:

Each Performance Right automatically converts into one Share upon vesting of the Performance Right;

Each Performance Right is subject to performance conditions (as determined by the Board from time to time) which must be satisfied in order for the Performance Right to vest;

The Performance Rights outstanding at the end of the financial year have the following performance conditions and expiry dates:

1,100,000 Performance Rights subject to the Feasibility Study Milestone expiring on December 31, 2018;

200,000 Performance Rights subject to the Mineral Resource Milestone expiring on December 31, 2019; and

200,000 Performance Rights subject to the Scoping Study Milestone expiring on December 31, 2020;

Shares issued on conversion of the Performance Rights rank equally with the then Shares of the Company;

Application will be made by the Company to ASX for official quotation of the Shares issued upon conversion of the Performance Rights;

If there is any reconstruction of the issued share capital of the Company, the rights of the Performance Right holders may be varied to comply with the ASX Listing Rules which apply to the reconstruction at the time of the reconstruction;

No application for quotation of the Performance Rights will be made by the Company; and

Without approval of the Board, Performance Rights may not be transferred, assigned or novated, except, upon death, a participant's legal personal representative may elect to be registered as the new holder of such Performance Rights and exercise any rights in respect of them.

(e)
Movements in foreign currency translation reserve

  
2018
  
2017
  
2016
 
  
US$
  
US$
  
US$
 
Balance at July 1
  
318,122
   
259,320
   
317,222
 
Exchange differences arising on translation of foreign operations
  
(249,205
)
  
58,802
   
(57,902
)
Balance at June 30
  
68,917
   
318,122
   
259,320